WALDENSTRÖM'S MACROGLOBULINEMIA
Clinical trials for WALDENSTRÖM'S MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTRÖM'S MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTRÖM'S MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug study aims to control rare blood cancer
Disease control Recruiting nowThis study is testing how well the drug zanubrutinib works and how safe it is for Chinese adults who have just been diagnosed with Waldenström's Macroglobulinemia, a rare blood cancer, and have not yet received any treatment. The goal is to gather more real-world data on the drug…
Matched conditions: WALDENSTRÖM'S MACROGLOBULINEMIA
Phase: PHASE4 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Tracking a cancer Drug's Real-World impact on Patients' lives
Disease control Recruiting nowThis study aims to understand how the drug zanubrutinib works for adults with certain blood cancers in everyday clinic settings, not a controlled trial. It will follow about 705 patients to see how the treatment affects their quality of life, how often they need hospital care, an…
Matched conditions: WALDENSTRÖM'S MACROGLOBULINEMIA
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC